- Poster presentation
- Open Access
Chronic non-infectious osteitis: single centre case series
© Dawson et al. 2015
- Published: 28 September 2015
- Bisphosphonate Therapy
- Insidious Onset
Chronic non-infectious osteitis (CNO), also known as Chronic Recurrent Multifocal Osteomyelitis, is a non-infectious inflammatory osteopathy predominantly affecting children and adolescents. Diagnosis is often difficult as initial symptoms and clinical course can vary widely. CNO can result in significant morbidity. Treatment regimes are varied but bisphosphonate therapy with pamidronate is proving effective at reducing pain and improving bone remodelling in some patients.
To review the presentation, diagnosis, management and clinical course of patients with CRMO in one paediatric centre.
Case-notes of forty seven patients undergoing treatment for CNO from 2003 to 2015 at Bristol Children's Hospital were analysed and details entered into a custom-made spreadsheet containing eighty two parameters. In order to establish the criteria that had been used for diagnosis, plain films, CT, MRI, bone scans and biopsy results were recorded alongside presenting characteristics.
Median age at presentation was 10 years (range 1.5 to 14). 33 were female, 14 male. The initial differential diagnoses included Langerhans Cell histiocytosis (5), malignancy (4), infectious osteomyelitis (12), arthritis (4), musculoskeletal (5), other viral illness (11) and CNO (6). All patients had x-ray and MRI studies. Whole body STIR MRI was used to detect silent areas of osteitis and monitor treatment. The predominant sites of bony involvement on MRI included femur (12), clavicle (9), tibia (13) and spine (14). 25 patients underwent bone biopsy and all had extensive microbiological investigations, with no organisms identified. Mean time from initial presentation to medical services to diagnosis was 26 months (range 1-84). 24 of patients had been initially treated with at least one course of antibiotics for a presumed infectious osteomyelitis. Patients were also treated with NSAIDs (42), steroids (5) and DMARDs (8), although only a small proportion had pain cessation. 24 patients received pamidronate, of which 12 completed the course. Of those who completed the course 4 had persistent pain and 8 had pain cessation.
This cohort is one of the largest series in the literature. It is important to increase awareness of CRMO as a diagnostic differential when a child presents with insidious onset bone pain. MRI STIR provides important evidence in the diagnosis of CRMO. A central database would facilitate a greater understanding of the diagnostic criteria and treatment options. Pamidronate has thus far appered effective in the management of 8 patients.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.